Short answer
Tyra Biosciences, Inc. (TYRA) filed an 8-K current report with the SEC on March 4, 2026 reporting Item 8.01 (Other Events). Equity raise: 4,000,000 shares sold at $31.50/share to a single large institutional buyer via block transaction.
Tyra Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Equity raise: 4,000,000 shares sold at $31.50/share to a single large institutional buyer via block transaction
- Gross proceeds $126.0M before fees, executed under existing ATM program registered May 2025
- Single-buyer block structure signals strong institutional conviction vs. typical ATM drip selling
- Dilution event: new shares ~represent immediate increase to share count; investors should monitor post-offering float impact
- Proceeds likely to extend cash runway for pipeline/clinical programs: use of proceeds not yet specified
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tyra Biosciences, Inc. 8-K filings
Get the next TYRA 8-K as it lands
Follow TYRA for push alerts, or ask the research agent what this filing means.